Daptomycin for the treatment of gram-positive infections after cardiac surgery

被引：0
|
作者：
Luchting, B. [1 ]
Weis, F. [1 ]
Heyn, J. [1 ]
Beiras-Fernandez, A. [2 ,3 ]
机构：
[1] Klinikum Univ Munchen, Klin Anaesthesiol, Munich, Germany
[2] Klinikum Univ Munchen, Herzchirurg Klin & Poliklin, Munich, Germany
[3] Klinikum Johann Wolfgang Goethe Univ, D-60590 Frankfurt, Germany
来源：
MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN | 2013年 / 108卷 / 01期
关键词：
Gram-positive Infections; Daptomycin; Cardiac surgery; Resistences; Efficacy; RESISTANT STAPHYLOCOCCUS-AUREUS; MAJOR HEART-SURGERY; POSTOPERATIVE MEDIASTINITIS; CLINICAL-EVIDENCE; JOINT INFECTIONS; VANCOMYCIN; THERAPY; ENDOCARDITIS; BACTEREMIA; PATIENT;
D O I：
10.1007/s00063-012-0163-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background and method. Surgical infection remains a main cause of death after heart surgery, despite advances in pharmacological therapy. Daptomycin is a cyclic lipopeptide antibiotic, useful in gram-positive organisms resistant to standard treatment, including vancomycin. The aim of this study was to describe the use of daptomycin regarding efficacy, efficiency and safety in patients with gram-positive infections after heart surgery using a retrospective analysis on 49 adult patients. Conclusion. Daptomycin shows excellent in vitro and in vivo activity against gram-positive organisms, such as Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, especially MRSA. Daptomycin is also effective against increasing vancomycin-resistant or vancomycin-intermediate S. aureus.
引用
收藏
页码：59 / 62
页数：4
相关论文
共 50 条
  • [41] Antibiotics for Gram-Positive Bacterial Infections: Vancomycin, Teicoplanin, Quinupristin/Dalfopristin, Oxazolidinones, Daptomycin, Dalbavancin, and Telavancin
    Nailor, Michael D.
    Sobel, Jack D.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2009, 23 (04) : 965 - +
  • [42] Vancomycin versus daptomycin for the treatment of confirmed gram-positive catheter-related bloodstream infections in oncology patients
    del Rosario-Garcia, Betel
    Julia Nazco-Casariego, Gloria
    Luis Gomez-Sirvent, Juan
    Garcia-Marrero, Rosa
    Garcia-Rosado, Dacil
    Maria Lopez-Lirola, Ana
    Maria Oramas-Rodriguez, Juana
    Gonzalez-Garcia, Jonathan
    FARMACIA HOSPITALARIA, 2022, 46 (03) : 105 - 108
  • [43] Daptomycin as a promising antimicrobial agent for the treatment of serious infections caused by resistant gram-positive organisms
    Tarai, B.
    Das, P.
    Kumar, D.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 32 (03) : 353 - 354
  • [44] Comparison of efficacy and safety between daptomycin plus β-lactam and daptomycin monotherapy for bloodstream infections due to gram-positive cocci: A systematic review and meta-analysis
    Umemura, Takumi
    Kato, Hideo
    Asai, Nobuhiro
    Hagihara, Mao
    Hirai, Jun
    Yamagishi, Yuka
    Mikamo, Hiroshige
    HELIYON, 2024, 10 (08)
  • [45] Future treatment options for Gram-positive infections-looking ahead
    Barton, E.
    MacGowan, A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 : 17 - 25
  • [46] Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery
    Weis, Florian
    Heyn, Jens
    Hinske, Christian L.
    Vogt, Ferdinand
    Weis, Marion
    Kur, Felix
    Hagl, Christian
    Beiras-Fernandez, Andres
    JOURNAL OF CARDIOTHORACIC SURGERY, 2012, 7
  • [47] Dalbavancin for the Treatment of Complicated Gram-Positive Skin and Soft Tissue Infections
    Petrakis, Vasilios
    Panagopoulos, Periklis
    Papanas, Nikolaos
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2020, 19 (03) : 236 - 241
  • [48] A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections
    Blaskovich, Mark A. T.
    Hansford, Karl A.
    Butler, Mark S.
    Ramu, Soumya
    Kavanagh, Angela M.
    Jarrad, Angie M.
    Prasetyoputri, Anggia
    Pitt, Miranda E.
    Huang, Johnny X.
    Lindahl, Fredrik
    Ziora, Zyta M.
    Bradford, Tanya
    Muldoon, Craig
    Rajaratnam, Premraj
    Pelingon, Ruby
    Edwards, David J.
    Zhang, Bing
    Amado, Maite
    Elliott, Alysha G.
    Zuegg, Johannes
    Coin, Lachlan
    Woischnig, Anne-Kathrin
    Khanna, Nina
    Breidenstein, Elena
    Stincone, Anna
    Mason, Clive
    Khan, Nawaz
    Cho, Hye-Kyung
    Karau, Melissa J.
    Greenwood-Quaintance, Kerryl E.
    Patel, Robin
    Wootton, Mandy
    James, Meagan L.
    Hutton, Melanie L.
    Lyras, Dena
    Ogunniyi, Abiodun D.
    Mahdi, Layla K.
    Trott, Darren J.
    Wu, Xiaoqian
    Niles, Samantha
    Lewis, Kim
    Smith, Jordan R.
    Barber, Katie E.
    Yim, Juwon
    Rice, Seth Alan
    Rybak, Michael J.
    Ishmael, Chad R.
    Hori, Kellyn R.
    Bernthal, Nicholas M.
    Francis, Kevin P.
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (662)
  • [49] Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci
    Cervera, Carlos
    Castaneda, Ximena
    Pericas, Juan M.
    del Rio, Ana
    Garcia de la Maria, Cristina
    Mestres, Carlos
    Falces, Carlos
    Marco, Francesc
    Moreno, Asuncion
    Miro, Jose M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (05) : 365 - 370
  • [50] Daptomycin for Pediatric Gram-Positive Acute Hematogenous Osteomyelitis
    Bradley, John S.
    Arrieta, Antonio C.
    Digtyar, Valeri A.
    Popejoy, Myra W.
    Grandhi, Anjana
    Bokesch, Paula
    Hershberger, Ellie
    Dorr, Mary Beth
    Tan, Christopher M.
    Murata, Yoshihiko
    Wolf, Dominik J.
    Bensaci, Mekki
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (09) : 814 - 823
12345